Knight Therapeutics Inc. Ranks No. 90 on Canada's Top Growing Companies List
Knight Therapeutics Inc. (TSX:GUD) is proud to announce its placement at No. 90 on the 2023 Report on Business ranking of Canada's Top Growing Companies. This prestigious list evaluates Canadian companies based on their three-year revenue growth, and Knight secured its position with an impressive growth rate of 515%.
"We are honored to be recognized as one of Canada's Top Growing Companies for the third consecutive year," said Samira Sakhia, President and CEO of Knight Therapeutics. Sakhia expressed gratitude for her team's exceptional performance, which contributes to Knight's success as a leading specialty pharmaceutical company operating across 11 countries and two continents.
The Canada's Top Growing Companies ranking, launched in 2019, celebrates entrepreneurial achievements and showcases innovative businesses in Canada. To qualify for this voluntary program, companies undergo a rigorous application process and meet specific requirements. This year, a total of 425 companies earned a spot on the list, highlighting their remarkable growth.
Dawn Calleja, Editor of Report on Business magazine, described Canada's Top Growing Companies as an acknowledgment of the drive and ingenuity displayed by Canadian businesses. She believes that this year's ranking will serve as an inspiration for future business owners.
Knight Therapeutics' inclusion on this list demonstrates their ability to thrive and surpass economic challenges. The Globe and Mail congratulates all the winners for their remarkable achievements.
About The Globe and Mail:
The Globe and Mail is Canada's leading news media company, known for its independent and impactful journalism since 1844. With award-winning coverage of business, politics, and national affairs, The Globe and Mail reaches millions of readers weekly in print and digital formats.
About Knight Therapeutics Inc.:
Headquartered in Montreal, Canada, Knight Therapeutics is a specialty pharmaceutical company focused on acquiring, in-licensing, and commercializing pharmaceutical products in Canada and Latin America. Operating through its Latin American subsidiaries, Knight aims to bring high-quality products, innovation, and value to the markets it serves.
Note: This document contains forward-looking statements. For more information, please refer to Knight Therapeutics Inc.'s Annual Report and Annual Information Form, available on www.sedar.com. Knight Therapeutics Inc. disclaims any intention or obligation to update or revise any forward-looking statements, except as required by law.
Impact of Knight Therapeutics' Ranking on New Businesses
Knight Therapeutics Inc.'s placement at No. 90 on Canada's Top Growing Companies list is not only a testament to their impressive growth rate of 515%, but also serves as a beacon of inspiration for new businesses. This prestigious ranking, which evaluates companies based on their three-year revenue growth, underscores the importance of robust financial performance and strategic growth initiatives.
Significance of Recognition
Knight Therapeutics' recognition as one of Canada's Top Growing Companies for the third consecutive year is a powerful endorsement of their business model and growth strategy. For new businesses, this highlights the value of persistence, innovation, and a dedicated team in achieving sustained growth and industry recognition.
Role Model for Entrepreneurial Success
Knight Therapeutics' success story provides a roadmap for new businesses, demonstrating how a specialty pharmaceutical company can thrive and surpass economic challenges in a competitive market. Their focus on acquiring, in-licensing, and commercializing pharmaceutical products across multiple markets underlines the importance of diversification and market expansion.
While Knight Therapeutics continues to excel, it's crucial for new businesses to note that this success is backed by a commitment to continuous improvement and adaptability, as reflected in their forward-looking statements. This underlines the importance of strategic foresight and flexibility in business growth and longevity.